Mauna Kea Technologies enrolls 200+ patients in study, Miraca Life Sciences launches eosinophilic esophagitis test & more – 4 GI company key notes

Here are four recent news updates on key gastroenterology and endoscopy companies.

Zacks Investment Research upgraded EndoChoice from a "hold" rating to a "buy" rating.

SpectraScience acquired the assets of Oncoscope.

Mauna Kea Technologies enrolled more than 200 patients in its CONTACT II clinical study.

Miraca Life Sciences launched the EoGenius test, which helps diagnose and monitor patients with eosinophilic esophagitis.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast